Skip to main content

News

July 23, 2025

bioMérieux and Moderna Collaborate to Advance individualized Cancer Therapies

bioMérieux has a long history of collaboration with Moderna, a biotechnology company that gained worldwide recognition during the COVID-19 pandemic for its rapid development of a mRNA-based vaccine. Today, this partnership is helping accelerate the development of individualized cancer treatments.